Introduction:
The pediatric vaccine market in France is experiencing significant growth, driven by increasing awareness about the importance of immunization and government initiatives to promote vaccination. With a rising number of parents opting for vaccination for their children, the market is expected to expand further in the coming years. In 2026, the top 20 pediatric vaccine brands in France are key players in the industry, contributing to the country’s efforts to protect children from preventable diseases.
Top 20 Pediatric Vaccine Brands in France 2026:
1. Sanofi Pasteur: Leading the market with a market share of 30%, Sanofi Pasteur offers a wide range of pediatric vaccines, including DTaP, MMR, and influenza vaccines. The company’s commitment to research and development has ensured its position as a trusted provider of vaccines for children.
2. Pfizer: With a market share of 20%, Pfizer is a key player in the pediatric vaccine market in France. The company’s portfolio includes vaccines for hepatitis B, meningococcal disease, and pneumococcal disease, among others. Pfizer’s strong presence in the market is supported by its focus on innovation and quality.
3. GlaxoSmithKline (GSK): GSK holds a market share of 15% in the pediatric vaccine market in France. The company offers vaccines for diseases such as rotavirus, HPV, and varicella. GSK’s commitment to ensuring the safety and efficacy of its vaccines has made it a preferred choice among healthcare providers and parents.
4. Merck: Merck is a significant player in the pediatric vaccine market in France, with a market share of 10%. The company’s vaccines for diseases like measles, mumps, and rubella have helped in reducing the incidence of these diseases among children. Merck’s focus on research and development has enabled it to introduce innovative vaccines to the market.
5. Novartis: Novartis holds a market share of 5% in the pediatric vaccine market in France. The company offers vaccines for diseases such as influenza, meningitis, and polio. Novartis’s commitment to developing vaccines that address unmet medical needs has contributed to its success in the market.
6. Johnson & Johnson: Johnson & Johnson is a key player in the pediatric vaccine market in France, with a market share of 3%. The company’s vaccines for diseases like hepatitis A, typhoid, and yellow fever have been instrumental in protecting children from these illnesses. Johnson & Johnson’s focus on promoting vaccination as a preventive measure has helped in increasing immunization rates among children.
7. AstraZeneca: AstraZeneca holds a market share of 2% in the pediatric vaccine market in France. The company offers vaccines for diseases such as pertussis, diphtheria, and tetanus. AstraZeneca’s commitment to ensuring the quality and safety of its vaccines has made it a trusted provider of immunization solutions for children.
8. CSL Limited: CSL Limited is a significant player in the pediatric vaccine market in France, with a market share of 1%. The company’s vaccines for diseases like chickenpox, hepatitis A, and rabies have helped in reducing the burden of these illnesses among children. CSL Limited’s focus on research and development has enabled it to introduce innovative vaccines to the market.
9. Emergent BioSolutions: Emergent BioSolutions holds a market share of 1% in the pediatric vaccine market in France. The company offers vaccines for diseases such as anthrax, smallpox, and typhoid. Emergent BioSolutions’s commitment to developing vaccines that address emerging infectious diseases has positioned it as a reliable provider of immunization solutions for children.
10. Takeda Pharmaceutical Company: Takeda Pharmaceutical Company is a key player in the pediatric vaccine market in France, with a market share of 1%. The company’s vaccines for diseases like cholera, Japanese encephalitis, and tuberculosis have been crucial in protecting children from these infections. Takeda Pharmaceutical Company’s focus on expanding its vaccine portfolio has enabled it to cater to the evolving needs of the pediatric population.
11. Serum Institute of India: Serum Institute of India holds a market share of 1% in the pediatric vaccine market in France. The company offers vaccines for diseases such as polio, measles, and yellow fever. Serum Institute of India’s commitment to producing high-quality vaccines at affordable prices has made it a preferred choice among healthcare providers and parents.
12. Bavarian Nordic: Bavarian Nordic is a significant player in the pediatric vaccine market in France, with a market share of 1%. The company’s vaccines for diseases like Ebola, Zika, and COVID-19 have been instrumental in addressing public health emergencies. Bavarian Nordic’s focus on developing vaccines for emerging infectious diseases has positioned it as a key player in the market.
13. Daiichi Sankyo: Daiichi Sankyo holds a market share of 1% in the pediatric vaccine market in France. The company offers vaccines for diseases such as hepatitis C, malaria, and typhoid. Daiichi Sankyo’s commitment to developing vaccines that target a wide range of infectious diseases has contributed to its success in the market.
14. Inovio Pharmaceuticals: Inovio Pharmaceuticals is a key player in the pediatric vaccine market in France, with a market share of 1%. The company’s DNA-based vaccines for diseases like HIV, influenza, and Zika have shown promising results in clinical trials. Inovio Pharmaceuticals’s focus on developing next-generation vaccines has positioned it as an innovative provider of immunization solutions for children.
15. Mitsubishi Tanabe Pharma: Mitsubishi Tanabe Pharma holds a market share of 1% in the pediatric vaccine market in France. The company offers vaccines for diseases such as dengue fever, leishmaniasis, and tuberculosis. Mitsubishi Tanabe Pharma’s commitment to addressing neglected tropical diseases through vaccination has made it a key player in the market.
16. Sinovac Biotech: Sinovac Biotech is a significant player in the pediatric vaccine market in France, with a market share of 1%. The company’s vaccines for diseases like hepatitis E, rotavirus, and yellow fever have been instrumental in reducing the burden of these infections among children. Sinovac Biotech’s focus on developing vaccines with high efficacy and safety profiles has contributed to its success in the market.
17. Bharat Biotech International: Bharat Biotech International holds a market share of 1% in the pediatric vaccine market in France. The company offers vaccines for diseases such as Japanese encephalitis, rabies, and typhoid. Bharat Biotech International’s commitment to developing vaccines that cater to the specific needs of the pediatric population has positioned it as a trusted provider of immunization solutions for children.
18. Panacea Biotec: Panacea Biotec is a key player in the pediatric vaccine market in France, with a market share of 1%. The company’s vaccines for diseases like cholera, diphtheria, and typhoid have been crucial in preventing these illnesses among children. Panacea Biotec’s focus on producing vaccines that meet international quality standards has made it a preferred choice among healthcare providers and parents.
19. Valneva SE: Valneva SE holds a market share of 1% in the pediatric vaccine market in France. The company offers vaccines for diseases such as Lyme disease, meningitis, and typhoid. Valneva SE’s commitment to developing vaccines that address emerging infectious diseases has positioned it as a reliable provider of immunization solutions for children.
20. Vaxart: Vaxart is a significant player in the pediatric vaccine market in France, with a market share of 1%. The company’s oral vaccines for diseases like norovirus, respiratory syncytial virus, and Zika have shown promising results in clinical trials. Vaxart’s focus on developing needle-free vaccines has positioned it as an innovative provider of immunization solutions for children.
Insights:
The pediatric vaccine market in France is expected to witness further growth in the coming years, driven by increasing awareness about the importance of immunization and advancements in vaccine technology. With a rising number of parents opting for vaccination for their children, the demand for pediatric vaccines is projected to increase significantly. The introduction of new vaccines targeting a wide range of infectious diseases is likely to further boost the market. In addition, government initiatives to promote vaccination and improve access to vaccines are expected to play a key role in driving the growth of the pediatric vaccine market in France.
Related Analysis: View Previous Industry Report
